These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1973370)

  • 1. Synthetic peptides: prospects for a pili (fimbriae)-based synthetic vaccine.
    Schmidt MA
    Curr Top Microbiol Immunol; 1990; 151():185-204. PubMed ID: 1973370
    [No Abstract]   [Full Text] [Related]  

  • 2. Pilus vaccines.
    Tramont EC; Boslego JW
    Vaccine; 1985 Mar; 3(1):3-10. PubMed ID: 2408396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilus peptide vaccine for the prevention of gonorrhea.
    Schoolnik GK; Tai JY; Gotschlich EC
    Prog Allergy; 1983; 33():314-31. PubMed ID: 6187017
    [No Abstract]   [Full Text] [Related]  

  • 4. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
    Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
    Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-fimbriae vaccines. I. Cross reactive antibodies to heterologous P-fimbriae.
    Kaack MB; Pere A; Korhonen TK; Svenson SB; Roberts JA
    Pediatr Nephrol; 1989 Oct; 3(4):386-90. PubMed ID: 2577146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant DNA technology and enterotoxigenic Escherichia coli vaccines.
    Gyles CL; Maas WK
    Prog Vet Microbiol Immunol; 1987; 3():139-58. PubMed ID: 3078832
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Langermann S; Palaszynski S; Barnhart M; Auguste G; Pinkner JS; Burlein J; Barren P; Koenig S; Leath S; Jones CH; Hultgren SJ
    Science; 1997 Apr; 276(5312):607-11. PubMed ID: 9110982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of pili k88 and k99 as protecting antigens: immunization against enteric swine colibacillosis by sow vaccination.
    Avila FA; Avila SH; Schocken-Iturrino RP; Marques MA
    Rev Elev Med Vet Pays Trop; 1986; 39(3-4):293-6. PubMed ID: 2889243
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological parameters associated with antigenic competition in a multivalent footrot vaccine.
    Hunt JD; Jackson DC; Wood PR; Stewart DJ; Brown LE
    Vaccine; 1995 Dec; 13(17):1649-57. PubMed ID: 8719515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular basis of the immune response to conjugate vaccines.
    Bixler GS; Pillai S
    Contrib Microbiol Immunol; 1989; 10():18-47. PubMed ID: 2684506
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccinating with bacterial pili.
    Marx JL
    Science; 1980 Sep; 209(4461):1103-6. PubMed ID: 6105710
    [No Abstract]   [Full Text] [Related]  

  • 12. Design and development of pilus vaccines for Haemophilus influenzae diseases.
    Brinton CC; Carter MJ; Derber DB; Kar S; Kramarik JA; To AC; To SC; Wood SW
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S54-61. PubMed ID: 2564658
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man.
    Levine MM; Black RE; Brinton CC; Clements ML; Fusco P; Hughes TP; O'Donnell S; Robins-Browne R; Wood S; Young CR
    Scand J Infect Dis Suppl; 1982; 33():83-95. PubMed ID: 6127806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
    Pecha B; Low D; O'Hanley P
    J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New vaccines may ward off urinary tract infections.
    Service RF
    Science; 1997 Apr; 276(5312):533. PubMed ID: 9148412
    [No Abstract]   [Full Text] [Related]  

  • 16. Conserved regions in the sequence of the F4 (K88) fimbrial adhesin FaeG suggest a donor strand mechanism in F4 assembly.
    Verdonck F; Cox E; Schepers E; Imberechts H; Joensuu J; Goddeeris BM
    Vet Microbiol; 2004 Sep; 102(3-4):215-25. PubMed ID: 15327796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
    Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in vaccines for mucosal non-enteric human bacterial pathogens.
    Westerink MA; Campagnari AA; Nelson MB; Murphy TF; Apicella MA
    Adv Exp Med Biol; 1989; 251():17-31. PubMed ID: 2481958
    [No Abstract]   [Full Text] [Related]  

  • 19. P-fimbriae of Escherichia coli as carriers for gonadotropin releasing hormone: development of a recombinant contraceptive vaccine.
    van der Zee A; Noordegraaf CV; van den Bosch H; Gielen J; Bergmans H; Hoekstra W; van Die I
    Vaccine; 1995; 13(8):753-8. PubMed ID: 7483791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptides protect against infection in a model of experimental pyelonephritis in mice.
    Schmidt MA; O'Hanley P; Schoolnik GK
    Ann Sclavo Collana Monogr; 1986; 3(1-2):389-98. PubMed ID: 3322342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.